环加氧酶-2抑制剂尼美舒利通过改善内皮功能和增加NO含量对抗大鼠心肌氧化应激损伤

本文旨在研究冠状动脉内皮和NO在选择性环加氧酶2（cyclooxygenase2,COX-2）抑制剂尼美舒利（nimesulide）对抗心肌氧化损伤中的作用。离体大鼠心脏行Langendorff灌流,给予H2O2（140Bmol／L）观察心脏收缩功能。用U-46619灌流心脏,使冠状动脉预收缩后,观察冠状动脉对内皮依赖性舒张因子5-HT和内皮非依赖性舒张因子硝普钠（sodiumnitroprusside,SNP）的反应。结果显示：（1）与空白对照组（100％）相比,H202灌流20min后,左心室发展压[left ventriculardevelo pedpressure,LVDP,（54．8±4．0）％],和心室内压最大变化速率【±dp／dtmax（50．8±3．1）％和（46．2±2．9）％]明显降低。H2O2灌流前尼美舒利（5μmol/L）预处理10min,能够显著抑制H2O2引起的LVDP和μdp/dtmax下降[（79．9±2．8）％,（80．3±2．6）％和（81．4±2．6）％,P〈0．0l]。（2）与空白对照组相比,H2O2灌流后,5-HT和SNP引起内皮依赖性和内皮非依赖性血管舒张功能均明显下降;而尼美舒利预处理10min能明显对抗内皮依赖性血管舒张功能的下降[（-22．2±4．2）％vsH2O2组（-6．0±2．5）％,P〈0．0l],但对其内皮非依赖性血管舒张功能的下降没有明显作用[（-2．0±1．8）％vsH202组（-7．0±3．5）％,P〉0．05]。（3）一氧化氮合酶（nitric oxide synthase,NOS）抑制剂L-NAME能够部分取消尼美舒利预处理对H20,应激心脏心功能指标的改善作用ILVDP和±dp/dtmax分别为（60．2±2．1）％,（63．9±2．4）％和（63．1±2．9）％,P〈0．01]。同时尼美舒利预处理10min能使H202应激心肌NO含量增加[（2．63±0．40）vs（1．36±0．23）nmol／gprotein,P〈0．051,而L-NAME抑制此作用。（4）选择性COX-1抑制剂吡罗昔康（piroxicam）预处理不能抑制H202引起的LVDP和±dp/dtmax下降,但促进左心室舒张末压（1eftventricular end diastolicpressure,LVEDP）升高;吡罗昔康对H202引起的内皮依赖性和内皮非依赖性血管舒张功能下降无显著作用。以上结果提示,选择性COX-2抑制剂尼美舒利能够对抗大鼠离体心肌氧化应激损伤,其机制可能是通过改善内皮依赖性血管舒张功能和增加心肌NO含量起作用。     

卵巢癌细胞系RMG-Ⅰ Lewis(y)抗原含量变化对其卡铂耐药性的影响

利用Lewis（y）抗原稳定高表达细胞株RMG-I-H,研究细胞表面Lewis（y）抗原含量变化与细胞对卡铂耐药性的关系．利用四甲基偶氮唑盐（MTT）法测定不同浓度卡铂作用后细胞系RMG-I—H及其对照组RMG-I、RMG-I—C的细胞生长抑制率（IR）;利用流式细胞仪（FCM）分析细胞凋亡,同时检测药物作用后细胞的凋亡比率;利用荧光染色法和透射电镜进一步观察细胞凋亡状态．结果表明,RMG-I-H的半数抑制浓度（IC50）为（58．07±2．42）,明显高于对照组RMG—I（28．83±3．57）和RMG-I-C（25．71±8．24）的IC50（P〈0．01）,后两者间无统计学差异（P〉0．05）,流式细胞仪分析证实3组细胞均存在凋亡,经30mg／L、60mg／L卡铂处理后细胞再进行流式细胞仪检测,RMG—I-H的相对凋亡率分别为（20．43±0．71m和（38．11±0．33）％,为对照组的49％-63％,明显低于对照组（P〈0．05）,2个对照组间比较无统计学差异（P〉0．05）,荧光染色和透射电镜直接观察了细胞形态变化,每个浓度组RMG-I-H的凋亡程度均低于RMG-I和RMG-I-C．说明细胞表面Lewis（y）抗原含量增加的同时,卵巢癌细胞对卡铂的耐药性增强．     

氨甲酰胆碱通过M2胆碱能受体对大鼠心肌细胞发挥正性肌力作用

为研究氨甲酰胆碱（carbachol,CCh）对大鼠心肌细胞的正性肌力作用机制,利用电压钳方法观察CCh对急性分离的单个大鼠心肌细胞L-型钙电流（足扎）和钠,钙交换电流（INa/Ca）的影响。细胞负载Fura-2／AM后,用离子成像系统测定场刺激下单个大鼠心肌细胞的钙瞬变和细胞缩短。结果表明,100ILmol／LCCh使正向INa/Ca从（1．18±0．57）pA／pF增加到（1．65±0．52）pA/pF（P〈O．01）,反向,INa/Ca从（1．11±0．49）pA/pF增加到（1．53±0．52）pA/pF（P〈O．01）,但不影响ICa,L。阿托品（非选择性M胆碱受体拮抗剂）和methoctramine（选择性M2胆碱受体拮抗剂）可阻断这种增加作用。100μmol／LCCh使钙瞬变从对照组的203．8±50．0增加到234．8±64.3,使细胞缩短从对照组的（3．00±0．67）μm增加到（3．55±1．21）μm。KB-R7943（选择性反向INa/Ca抑制剂）不影响钙瞬变和细胞缩短的基础水平,却完全阻断CCh引起的钙瞬变和细胞缩短的增加。尼卡地平（ICa,L抑制剂）抑制钙瞬变和细胞缩短。CCh在尼卡地平存在下仍可增加钙瞬变和细胞缩短值,提示其正性肌力作用是通过刺激钠,钙交换实现的。CCh不改变钙敏感性。阿托品和methoctramine阻断CCh的这种激动作用,说明CCh的正性肌力作用是通过M2受体实现的。以上结果提示,CCh对大鼠心肌细胞有正性肌力作用,这种作用是通过激动反向钠／钙交换实现,由M2受体介导。     

三氧化二砷脂质体透过载瘤大鼠血脑屏障的实验研究

目的：观察三氧化二砷（As2O3）脂质体通过载瘤大鼠血脑屏障（BBB）的效果。方法：超声薄膜分散法制备三氧化二砷脂质体,建立药物标准曲线,检测包封率;立体定向技术建立C6／Wistar大鼠脑胶质瘤模型;取Wistar雄性载瘤大鼠84只,随机分为三氧化二砷脂质体组和三氧化二砷组,分别经静脉注射三氧化二砷脂质体和三氧化二砷注射液,给药后0．5h、1h、2h、4h、8h、16h、24h取大鼠脑组织冻存,应用双道原子荧光法检测载瘤大鼠脑组织中的砷含量。结果：制备稳定的三氧化二砷脂质体,包封率分别为92、2％,92．2％,92．3％;As2O3脂质体组及As2O3给药后7个时间点鼠脑组织中砷含量（μg／L）分别为：341．09±18．18,523、98±27．36,475．19±15、52,467.02±22．46,471．52±24．38,382.30±13．26,282．47±19．71;99.93±17.10,148.07±26、21,101.78±17．54,89．09±19．41,74.39±13．85,50．44±15.31,51．52±19．23。比较给三氧化二砷组及给三氧化二砷脂质体组载瘤大鼠脑组织中砷含量有显著差异（P〈0．05）。结论：三氧化二砷脂质体对血脑屏障的透过性明显优于单纯砷剂。     

尼氟灭酸通过钙库钙释放引起豚鼠耳蜗螺旋动脉平滑肌细胞超极化(英文)

本研究旨在观察氯离子通道阻断剂尼氟灭酸（niflumic acid,NFA）引起豚鼠耳蜗螺旋动脉平滑肌细胞产生超极化的机制。以豚鼠为实验动物,运用细胞内微电极和全细胞膜片钳记录技术,观察NFA和其它药物对急性分离的耳蜗螺旋动脉平滑肌细胞的作用。结果显示：NFA、indanyloxyacetic acid94（LAh-94）和diSOdium4,4’-diisothiocyanatostilbene-2,2’-disulfonate（DIDS）可使低静息膜电位的细胞产生超极化,但对高静息膜电位的细胞无明显作用。低静息膜电位细胞的平均静息电位为（-42．47±1．38）mV（n=24）,100μmol／LNFA、10μmol／LIAA-94和200μmol／LDIDS分别使细胞超极化至（13．7±4．3）mV=9,P〈0．01）,（11．4±4．2）mV（n=7,P〈0．01）和（12．3±3．7）mV（n=8,P〈0．01）,这种氯离子通道阻断剂引起细胞超极化反应的效应呈浓度依赖性。NFA引起的超极化和外向电流几乎完全被100nmol／L iberiotoxin、100nmol／L charybdotoxin、10mmol／L tetraethylammonium、50μmol／LBAPTA—AM、10μmol／Lryanodine和0．1-10mmol／Lcaffeine阻断,但不能被100μmol／Lnifedipine、100μmol／LCdCI,和无Ca^2＋灌流外液阻断。结果捉示：氯离_了通道的阻断剂NFA可通过平滑肌细胞内钙库的钙释放增加细胞内钙,进而激活钙依赖的钾通道,产生耳蜗螺旋动脉平滑肌细胞的超极化反应。     

氨溴索对粘液型铜绿假单胞茵生物膜藻酸盐作用的体外研究

目的探讨氨溴索对铜绿假单胞菌临床分离株形成的生物膜（biofilm,BF）主要成分藻酸盐的干预作用,研究其对藻酸盐合成过程中起重要作用的基因表达和合成过程中限速酶活性的影响,以及其对藻酸盐降解的影响。方法建立铜绿似单胞菌临床分离株BF体外模型,培养7d后得到成熟BF。将BF内的细菌振荡下来后,用疏酸-苯酚法检测氨溴索对藻酸盐含量的影响;RT-PCR检测藻酸盐合成过程中重要基因algD、algU、algR和mucA的mRNA表达;分光光度计检测合成过程中限速酶——GDP-甘露糖脱氢酶（guanosine diphospho-D-mannose dehydrogenase,GMD）的活性,并检测藻酸盐的降解情况。结果在氨溴索3．75mg／ml作用下,藻酸盐含量（mg／g）由86．4024±0．8588下降到59．9199±0．5803（F=66．2,P〈0．01）;其合成重要基因algD、algU、algR和mucA的mRNA的表达分别由1．2994±0．0173、1．0488±0．0457、0．9888±0．0267和0．8731±0．0336变化为1．0253±0．0265、0．9594±0．0106、0．8536±0．0179和1．0770±0．0503（F=91．9,41．1,88．4和56,9,P均〈0．05）;其合成限速酶GMD活性由0．0989±0．0055下降到0．0558±0．0016（F=121．2,P〈0．01）;藻酸盐的降解量（△mg／g）由1．4122±0．0073变化为1．4175±0．0019（F=21．81,P〉0．05）。1．875mg／ml氨溴索作用下,有同样的趋势但效应不如高浓度明显。结论氨溴索可以降低铜绿假单胞菌BF藻酸盐的含量,影响藻酸盐合成过程中重要基因algD、algU、algR和mucA的mRNA的表达,降低藻酸盐合成限速酶GMD活性,但对藻酸盐的降解无影响。     

喉鳞癌患者血清中内皮抑素水平对喉鳞癌诊断价值的研究

目的：探讨喉鳞癌患者血清中内皮抑素水平的变化,及其与肿瘤临床分期及预后的关系。方法：（1）对50例喉鳞癌患者、30例喉息肉患者和30例健康人用ELISA方法检测血清中内皮抑素水平;（2）对喉鳞癌组不同临床分期的血清中内皮抑素的水平进行比较。结果：（1）喉鳞癌组血清中内皮抑素水平（51．45±19．83ng／mL）,显著高于喉息肉组（34．56±12．4ng／mL）和正常对照组（33．12±13．04ng／mL）,差别有统计学意义（P〈0．01）。喉息肉组与正常对照组之间差别无显著性（P〉0．05）。（2）Ⅱ期喉鳞癌患者血清内皮抑素的水平（66．22±10．89ng／mL）高于Ⅰ、Ⅱ期患者内皮抑素水平（39．31±14．42ng／mL,47．98±22．01ng／mL）,差别有统计学意义（P〈0．01）,Ⅰ期与Ⅱ期之间内皮抑素水平差别无显著性（P〉0．05）。结论：内皮抑素含量水平可以作为喉鳞癌的诊断及顸后判断的重要指标之一。     

欧洲小叶椴的胚培养与快速繁殖

1植物名称欧洲小叶椴（Tilia cordata Mill．）。 2材料类别成熟胚。 3培养条件（1）／3动培养基：MS＋6-BA2．0mg·L^-1（单位下同）＋NAA0．1;（2）增殖培养基：MS＋6．BA1．0＋NAA0．1;（3）壮苗生根培养基：1／2MS＋IBA1．0＋NAA0．3。以上培养基均加入0．55％琼脂和20g·L^-1。蔗精,pH5．8-6．0。培养温度为（25±2）℃;光照培养时间12h·d^-1,光照强度40．50μmol·m^-2·s^-1。     

冷冻对山羊精子转染外源DNA和体外制备转基因胚胎的影响

本实验将鲜精和冻精分别与地高锌标记的线形化的pEGFP-N,质粒孵育转染,用原位杂交方法检测转染效率;PCR和Southern Blotting检测精子与外源DNA的整合效率;与成熟卵母细胞体外受精,PCR检测阳性胚胎比率,用透射电镜技术、碘化丙锭和羟化荧光素双探针技术和单细胞电泳（Single Cell Gel Electrophoresis,SCGE）技术,观察精子冷冻前后的超微结构、精子质膜完整性和精子核DNA损伤的变化,研究冷冻对山羊（Caprahircus）精子转染内化外源DNA和体外制备转基因胚胎的影响及机理。结果表明,冻精显著提高了转染外源DNA的效率（81．60％±16．59％VS32．95％±2．93％,t=4．873,P=0．003;41．80％±6．26％vs27．89％±8．64％,t=2．634,P=0．039）。PCR和Southern Blotting检测表明外源DNA已经整合到精子基因组上。用冻精与成熟卵母细胞体外受精,体外受精穿透率和卵裂率显著低于鲜精组（24．19％±3．15％vs58．86％±3．73％,t=7．131,P〈0．001;11．83％±2．37％vs29．71±3．47％,t=4．302,P〈0．001）,但体外生产的胚胎PCR阳性率比鲜精组显著提高（45．45％±10．87％VS24．44％±6．06％,t=1．750,P=0．013）。超微结构观察和双荧光探针检测都发现冷冻-解冻精子质膜完整性降低（8．34％±4．21％VS65．67％±6．46％,t=12．492,P〈0．001）,SCGE显示冷冻极显著增加了精子彗尾长度和彗星细胞比例（42．67μm±4．56μmvs21．14／Lm±2．36μm,t=5．644,P=0．005;60．00％±4．00％vs17．37％±2．57％;t=15．787,P〈0．001）。冷冻-解冻可以提高山羊精子转染外源DNA的效率,冷冻破坏精子质膜完整性,解除质膜的阻碍作用,是提高外源DNA转染效率的一个主要原因[动物学报54（6）：1089-1097,2008]。     

天津八仙山自然保护区狍春季的卧息地利用

2007年春季,在天津八仙山自然保护区对狍卧息地利用进行了研究。共发现52个狍的卧息地,同时设置93个对照地。资源选择指数结果表明,狍偏好阔叶林,利用中上坡位,喜欢阳坡和半阴半阳坡,选择水源距离适中,偏爱远离人为干扰的卧息地。逐步判别分析结果显示,灌木盖度、隐蔽度、灌木高度、郁闭度、灌木距离和坡度是判别卧息地和对照地的关键因子,即为影响其卧息地利用的主要因子,判别正确率为98．1％。作为生性胆怯易惊的偶蹄类,具有隐蔽条件较好[灌木盖度适中（转换后为16．77±1．07。）、隐蔽度高（29．54±1．47m）、灌木高度稍高（1．22±0．05m）]的地点是狍适宜的卧息地,以逃避捕食者;与此同时,卧息地较舒适[郁闭度低（转换后为5．48±0．31°）、灌木距离较远（2．99±0．13m）、坡度小（2．11±0．09°）],以利于怀孕母狍呼吸与活动,反映其繁殖期生理需求。     

Atrial glutathione content, calcium current, and contractility

Atrial fibrillation (AF) is characterized by decreased L-type calcium current (I(Ca,L)) in atrial myocytes and decreased atrial contractility. Oxidant stress and redox modulation of calcium channels are implicated in these pathologic changes. We evaluated the relationship between glutathione content (the primary cellular reducing moiety) and I(Ca,L) in atrial specimens from AF patients undergoing cardiac surgery. Left atrial glutathione content was significantly lower in patients with either paroxysmal or persistent AF relative to control patients with no history of AF. Incubation of atrial myocytes from AF patients (but not controls) with the glutathione precursor N-acetylcysteine caused a marked increase in I(Ca,L). To test the hypothesis that glutathione levels were mechanistically linked with the reduction in I(Ca,L), dogs were treated for 48 h with buthionine sulfoximine, an inhibitor of glutathione synthesis. Buthionine sulfoximine treatment resulted in a 24% reduction in canine atrial glutathione content, a reduction in atrial contractility, and an attenuation of I(Ca,L) in the canine atrial myocytes. Incubation of these myocytes with exogenous glutathione also restored I(Ca,L) to normal or greater than normal levels. To probe the mechanism linking decreased glutathione levels to down-regulation of I(Ca), the biotin switch technique was used to evaluate S-nitrosylation of calcium channels. S-Nitrosylation was apparent in left atrial tissues from AF patients; the extent of S-nitrosylation was inversely related to tissue glutathione content. S-Nitrosylation was also detectable in HEK cells expressing recombinant human cardiac calcium channel subunits following exposure to nitrosoglutathione. S-Nitrosylation may contribute to the glutathione-sensitive attenuation of I(Ca,L) observed in AF.     

Transient outward potassium current in rabbit atrium is depressed after short-time rapid atrial pacing but recovers after a longer pacing period

In rabbit, after short-time rapid atrial pacing (RAP), atrial ion currents are reduced similarly as in human chronic atrial fibrillation (AF). Using the rabbit model, time-course of transient outward potassium current (I(to)) remodeling due to RAP was studied. RAP (600 bpm) was applied via an atrial lead for 0 (control), 24 and 120 h, n = 4 animals/group. Using patch clamp technique in whole-cell mode, current densities and biophysical properties were measured in isolated atrial myocytes. After 24 h of RAP, a reduction of peak I(to) (mean +/- SEM, test potential +50 mV, +37 degrees C) was observed (60.3 +/- 5.4 pA/pF (control, n = 20) vs. 28.0 +/- 2.5 pA/pF (24 h, n = 21)). Inactivation of I(to) was slower after 24 h, other biophysical properties were unaltered. However, I(to) recovered after 120 h: 51.7 +/- 4.5 pA/pF (n = 26, p = n.s. vs. control). Inactivation tended to also recover to initial values but was still different to control. Early I(to) remodeling due to RAP in rabbits seems to be more complex than previously thought: a time course of I(to) remodeling with swayings has to be considered when using the rabbit model of RAP in order to study early remodeling or rather its therapeutic manipulation.     

Atrial SERCA2a Overexpression Has No Affect on Cardiac Alternans but Promotes Arrhythmogenic SR Ca2+ Triggers

Background

Atrial fibrillation (AF) is the most common arrhythmia in humans, yet; treatment has remained sub-optimal due to poor understanding of the underlying mechanisms. Cardiac alternans precede AF episodes, suggesting an important arrhythmia substrate. Recently, we demonstrated ventricular SERCA2a overexpression suppresses cardiac alternans and arrhythmias. Therefore, we hypothesized that atrial SERCA2a overexpression will decrease cardiac alternans and arrhythmias.

Methods

Adult rat isolated atrial myocytes where divided into three treatment groups 1) Control, 2) SERCA2a overexpression (Ad.SERCA2a) and 3) SERCA2a inhibition (Thapsigargin, 1μm). Intracellular Ca²⁺ was measured using Indo-1AM and Ca²⁺ alternans (Ca-ALT) was induced with a standard ramp pacing protocol.

Results

As predicted, SR Ca²⁺ reuptake was enhanced with SERCA2a overexpression (p< 0.05) and reduced with SERCA2a inhibition (p<0.05). Surprisingly, there was no difference in susceptibility to Ca-ALT with either SERCA2a overexpression or inhibition when compared to controls (p = 0.73). In contrast, SERCA2a overexpression resulted in increased premature SR Ca2+ (SCR) release compared to control myocytes (28% and 0%, p < 0.05) and concomitant increase in SR Ca²⁺ load (p<0.05). Based on these observations we tested in-vivo atrial arrhythmia inducibility in control and Ad.SERCA2a animals using an esophageal atrial burst pacing protocol. There were no inducible atrial arrhythmias in Ad.GFP (n = 4) animals though 20% of Ad.SERCA2a (n = 5) animals had inducible atrial arrhythmias (p = 0.20).

Conclusions

Our findings suggest that unlike the ventricle, SERCA2a is not a key regulator of cardiac alternans in the atrium. Importantly, SERCA2a overexpression in atrial myocytes can increase SCR, which may be arrhythmogenic.     

Termination of atrial flutter by directed transesophageal atrial pacing during transesophageal echocardiography.

INTRODUCTION: The purpose of this study was to evaluate termination of atrial flutter (AFL) by directed rapid transesophageal atrial pacing (TAP) with and without simultaneous transesophageal echocardiography (TEE) performed using a novel TEE tube electrode. MATERIALS AND METHODS, AND RESULTS: A total of 16 AFL patients (age 63+/-12 years; 13 males) with mean AFL cycle length of 224+/-24 ms (n=12) and mean ventricular cycle length of 448+/-47 ms (n=12) were analyzed using either an esophageal TO electrode (n=10) or a novel TEE tube electrode consisting of a tube with four hemispherical electrodes that is pulled over the echo probe (n=6). AFL could be terminated by directed rapid TAP using an esophageal TO electrode, leading to induction of atrial fibrillation (AF) (n=6), induction of AF and spontaneous conversion to sinus rhythm (SR) (n=3), and with conversion to SR (n=1). AFL could also be terminated by directed rapid TAP using the TEE tube electrode, with induction of AF (n=3) or induction of AF and spontaneous conversion to SR (n=3). CONCLUSION: AFL can be terminated by directed rapid TAP with hemispherical electrodes with and without simultaneous TEE. TAP with the directed TEE tube electrode is a safe, simple, and useful method for terminating AFL.     

TWEAK/Fn14 mediates atrial‐derived HL‐1 myocytes hypertrophy via JAK2/STAT3 signalling pathway

Atrial myocyte hypertrophy is one of the most important substrates in the development of atrial fibrillation (AF). The TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy in cardiomyopathy. This study therefore investigated the effects of Fn14 on atrial hypertrophy and underlying cellular mechanisms using HL‐1 atrial myocytes. In patients with AF, Fn14 protein levels were higher in atrial myocytes from atrial appendages, and expression of TWEAK was increased in peripheral blood mononuclear cells, while TWEAK serum levels were decreased. In vitro, Fn14 expression was up‐regulated in response to TWEAK treatment in HL‐1 atrial myocytes. TWEAK increased the expression of ANP and Troponin T, and Fn14 knockdown counteracted the effect. Inhibition of JAK2, STAT3 by specific siRNA attenuated TWEAK‐induced HL‐1 atrial myocytes hypertrophy. In conclusion, TWEAK/Fn14 axis mediates HL‐1 atrial myocytes hypertrophy partly through activation of the JAK2/STAT3 pathway.     

超敏C反应蛋白与阵发性房颤射频消融术后早期复发的关系

目的：前瞻性研究超敏C反应蛋白（hsCRP）与阵发性心房颤动射频消融术后早期复发的关系。方法：接受CARTO指导房颤射频消融术的非瓣膜性阵发性房颤患者57例,平均年龄（53.32±9.98）岁,其中男42例,女15例。术前及术后5 d连续测定外周血hsCRP和高敏肌钙蛋白T （hs-cTnT）水平,记录体表心电图,行24 h动态心电图检查。术后5 d内,32名患者（56.14%）为窦性心律,为未复发组,25名（43.86%）复发房颤,为复发组。结果：未复发组与复发组患者的hsCRP与hs-cTnT日均升高量显著正相关,P=0.044,r=0.268。而两组间基线临床特征、手术前后血浆hsCRP、hs-cTnT水平、血浆hsCRP及hs-cTnT的总升高量（峰值水平-术前水平）、日均升高量（总升高量/达到峰值所用天数）无明显统计学差异（P均>0.05）。结论：房颤射频消融术后hsCRP升高变化与心肌损伤程度相关,与早期复发无直接关系,尚不能作为预测房颤术后早期复发的高危因子。     

Interstitial Cajal-like cells (ICLC) in atrial myocardium: ultrastructural and immunohistochemical characterization

We have previously reported (Hinescu & Popescu, 2005) the existence of interstitial Cajal-like cells (ICLC), by transmission electron microscopy, in human atrial myocardium. In the present study, ICLC were identified with non-conventional light microscopy (NCLM) on semi-thin sections stained with toluidine blue and immunohistochemistry (IHC) for CD117/c-kit, CD34, vimentin and other additional antigens for differential diagnosis. Quantitatively, on semi-thin sections, ICLC represent about 1-1.5% of the atrial myocardial volume (vs. approximately 45% working myocytes, approximately 2% endothelial cells, 3-4% for other interstitial cells, and the remaining percentage: extracellular matrix). Roughly, there is one ICLC for 8-10 working atrial myocytes in the intercellular space, beneath the epicardium, with a characteristic (pyriform, spindle or triangular) shape. These ICLC usually have 2-3 definitory processes, emerging from cell body, which usually embrace atrial myocytes (260 nm average distance plasmalemma/sarcolemma) or establish close contact with nerve fibers or capillaries (approximately 420 nm average distance to endothelial cells). Cell prolongations are characteristic: very thin (mean thickness = 0.15+/-0.1 microm), very long for a non-nervous cell (several tens of microm) and moniliform (uneven caliber). Stromal synapses between ICLC and other interstitial cells (macrophages) were found (e.g. in a multicontact type synapse, the average synaptic cleft was approximately 65 nm). Naturally, the usual cell organelles (mitochondria, smooth and rough endoplasmic reticulum, intermediate filaments) are relatively well developed. Caveolae were also visible on cell prolongations. No thick filaments were detected. IHC showed that ICLC were slightly and inconsistently positive for CD117/c-kit, variously co-expressed CD34 and EGF receptor, but appeared strongly positive for vimentin, along their prolongations. Some ICLC seemed positive for a-smooth muscle actin and tau protein, but were negative for nestin, desmin, CD13 and S-100. In conclusion, we provide further evidence of the existence of ICLC in human atrial myocardium, supporting the possible ICLC role in pacemaking, secretion (juxta- and/or paracrine), intercellular signaling (neurons and myocytes). For pathology, ICLC might as well be 'players' in arrhythmogenesis and atrial remodeling.     

Pituitary adenylate cyclase-activating polypeptide activates K(ATP) current in rat atrial myocytes

Because the electrophysiological effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on the heart are little known, we studied the regulation of the atrial ATP-sensitive K(+) (K(ATP)) current by PACAP on primary cultured neonatal rat atrial myocytes. PACAP-38 stimulates cAMP production with EC(50) = 0.28 nmol/l (r = 0.92, P < 0.02). PACAP-38 and PACAP-27 (10 nmol/l) have similar maximal effects, whereas 100 nmol/l vasoactive intestinal polypeptide (VIP) is 2.7 times less effective (P < 0.05). RT-PCR shows the presence of cloned PACAP receptors PAC(1) (> or =2 isoforms), VPAC(1), and VPAC(2). PACAP-38 dose dependently activates the whole cell atrial K(ATP) current with EC(50) = 1-3 nmol/l (n = 44). Maximal effects occur at 10 nmol/l (91 +/- 15 pA/pF, n = 18). Diazoxide further increases the PACAP-activated current by 78% (P < 0.05; n = 6). H(89) (500 nmol/l), a protein kinase A (PKA) inhibitor, reduces the PACAP-activated K(ATP) current to 17.8 +/- 9.6% (n = 5) of the maximal diazoxide-induced current and totally inhibits the cAMP-induced K(ATP) current. A protein kinase C (PKC) inhibitor peptide (50 micromol/l) in the pipette reduces the PACAP-38-induced K(ATP) current to 33 +/- 17 pA/pF (P < 0.05, n = 6) without significantly affecting the currents induced by cAMP or VIP. The results suggest that: 1) PAC(1), VPAC(1), and VPAC(2) are present in atrial myocytes; and 2) PACAP-38 activates the atrial K(ATP) channels through both PKA and PKC pathways.     

Decreased sarcolipin protein expression and enhanced sarco(endo)plasmic reticulum Ca2+ uptake in human atrial fibrillation

Sarcolipin (SLN), a key regulator of cardiac sarco(endo)plasmic reticulum (SR) Ca(2+) ATPase, is predominantly expressed in atria and mediates β-adrenergic responses. Studies have shown that SLN mRNA expression is decreased in human chronic atrial fibrillation (AF) and in aortic banded mouse atria; however, SLN protein expression in human atrial pathology and its role in atrial SR Ca(2+) uptake are not yet elucidated. In the present study, we determined the expression of major SR Ca(2+) handling proteins in atria of human AF patients and in human and in a mouse model of heart failure (HF). We found that the expression of SR Ca(2+) uptake and Ca(2+) release channel proteins are significantly decreased in atria but not in the ventricles of pressure-overload induced HF in mice. In human AF and HF, the expression of SLN protein was significantly decreased; whereas the expressions of other major SR Ca(2+) handling proteins were not altered. Further, we found that the SR Ca(2+) uptake was significantly increased in human AF. The selective downregulation of SLN and enhanced SR Ca(2+) uptake in human AF suggest that SLN downregulation could play an important role in abnormal intracellular Ca(2+) cycling in atrial pathology.